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Abstract
Background: Macrophages infected with Mycobacterium tuberculosis (M.tb) are known to be refractory to IFN-c stimulation.
Previous studies have shown that M.tb express components such as the 19-kDa lipoprotein and peptidoglycan that can bind
to macrophage receptors including the Toll-like receptor 2 resulting in the loss in IFN-cresponsiveness. However, it is
unclear whether this effect is limited to infected macrophages. We have previously shown that M.tb-infected macrophages
release exosomes which are 30–100 nm membrane bound vesicles of endosomal origin that function in intercellular
communication. These exosomes contain mycobacterial components including the 19-kDa lipoprotein and therefore we
hypothesized that macrophages exposed to exosomes may show limited response to IFN-c stimulation.
Methodology/Principal Findings: Exosomes were isolated from resting as well as M.tb-infected RAW264.7 macrophages.
Mouse bone marrow-derived macrophages (BMMØ) were treated with exosomes +/2 IFN-c. Cells were harvested and
analyzed for suppression of IFN-c responsive genes by flow cytometry and real time PCR. We found that exosomes derived
from M.tb H37Rv-infected but not from uninfected macrophages inhibited IFN-c induced MHC class II and CD64 expression
on BMMØ. This inhibition was only partially dependent on the presence of lipoproteins but completely dependent on TLR2
and MyD88. The exosomes isolated from infected cells did not inhibit STAT1 Tyrosine phosphorylation but down-regulated
IFN-c induced expression of the class II major histocompatibity complex transactivator; a key regulator of class II MHC
expression. Microarray studies showed that subsets of genes induced by IFN-c were inhibited by exosomes from H37Rv-
infeced cells including genes involved in antigen presentation. Moreover, this set of genes partially overlapped with the IFN-
c-induced genes inhibited by H37Rv infection.
Conclusions: Our study suggests that exosomes, as carriers of M.tb pathogen associated molecular patterns (PAMPs), may
provide a mechanism by which M.tb may exert its suppression of a host immune response beyond the infected cell.
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Introduction
Interferon-c plays a critical role in host response to M. tuberculosis
infection [1]. It activates macrophages to control intracellular M.
tuberculosis (M.tb) by inducing the expression of nitric oxide synthase 2
[2] and phagocyte oxidase [3] thus triggering the production of
reactive nitrogen and oxygen intermediates respectively. Moreover, it
facilitates antigen processing and presentation by macrophages to
CD4+T cells by upregulating MHC class IIexpression [4]. It has also
been reported that IFN-c induces autophagy which facilitates M.tb
killing and this is due, at least in part, to the activation of IFN-c
inducible immunity relatedGTPase Irgm1, also known as LRG-
47[5,6,7].However,althoughIFN-ctreatmentpromotesmacrophag-
e’sabilitytocontrolinfection,ithasbeenshownthatM.tb-infectedcells
are partially resistant to IFN-c stimulation. This includes infected
macrophagesbeingrefractorytoIFN-ckillingofM.tb.[8].Atleasttwo
different mycobacterial components have been identified that inhibit
macrophageresponsetoIFN-c,namelylipoproteinsincludingthe19-
kDa lipoprotein and the mycolylarabinogalactanpeptidoglycan
complex (mAGP complex) [9,10,11]. However, it is unclear if the
effect of these mycobacterial components is limited to infected
macrophages or whether mycobacterial components can gain access
to adjacent uninfected macrophages and if so what is the mechanism
involved?
Previous studies by Johnstone and coworkers identified an
alternative pathway for extracellular release of transferrin
receptors during reticulocyte differentiation [12]. They showed
that multivesicular bodies (MVBs) that are formed by the
invagination of the limiting endosomal membrane and are
known to transport membrane proteins and lipids to the
lysosome for degradation, could also fuse with the plasma
membrane and release the intraluminal vesicles into the
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the name exosomes, are secreted by cells of hematopoietic and
non-hematopoietic origin and are generally thought to function
in intercellular communication [13]. It has been shown
previously that mycobacterial components including the 19-
kDa lipoprotein are trafficked to the MVBs and subsequently
released from cells via exosomes [14,15]. The exosomes released
from M.tb-infected macrophages can interact with cells of the
immune system stimulating macrophage production of pro-
inflammatory mediators such as TNF-a as well as activation of
naı ¨ve antigen-specific T cells in vivo [16]. However, exosomes
containing mycobacterial components may also modulate
macrophage function to promote mycobacterial survival. One
possible mechanism in this context is the potential for exosomes
to render macrophages refractory to subsequent activation by
IFN-c. Indeed, we found that exposure of naı ¨ve macrophages to
exosomes derived from M.tb-infected cells renders the macro-
phages refractory to subsequent IFN-c activation for a subset of
genes. This list partially overlaps with IFN-c-induced genes
suppressed by M.tb infection and suggest that the ability of M.tb
infection to suppress IFN-c stimulation may not be limited to
infected cells.
Results
Exosomes derived from H37Rv-infected macrophages
inhibit IFN-c-induced MHC Class II and CD64 surface
expression on naı ¨ve murine macrophages
Exosomes were isolated from RAW264.7 macrophages infected
with M. tuberculosis H37Rv or from uninfected cells. Naı ¨ve C57BL/
6 bone marrow-derived macrophages (BMMØ) were stimulated
with exosomes for 18 hours followed by IFN-c treatment for an
additional 18 hours. Exosomes were removed prior to IFN-c
treatment. The cells were harvested and analyzed for MHC class
II and CD64 surface expression by flow cytometry. As expected,
treatment of macrophages with IFN-c markedly upregulated the
number of macrophages expressing MHC class II (Fig. 1A and
1B)and CD64 (Fig. 1C and 1D) in comparison to resting cells.
Prior treatment with exosomes from infected cells mitigated this
IFN-c-induced MHC class II and CD64 expression (Fig. 1A–D).
Exosomes from uninfected cells did not inhibit the MHC class II
or CD64 upregulation by IFN-c nor did treatment with these
exosomes alone lead to any significant increase in the surface
expression of these proteins. In contrast, exosomes released from
infected cells when added to BMMØ increased expression of
MHC class II and CD64 approximately 2 fold but no further
increase was observed upon IFN-c stimulation.
The inhibition of IFN-c induced MHC class II and CD64
expression by M.tbexosomes was partially dependent on
the presence of lipoproteins but completely dependent
on TLR2 and MyD88
It is known that purified M.tuberculosis 19-kDa lipoprotein
inhibits the induction of a subset of IFN-c responsive genes
through a TLR2 dependent manner. However, live virulent M.tb
inhibits macrophage response to IFN-c independent of mature
mycobacterial lipoproteins [17]. We therefore hypothesized that
exosomes derived from infected cells might also not require
lipoprotein. To test this hypothesis, we compared the ability of
exosomes released from cells infected with either wild-type or
LspA-deficient H37Rv to inhibit the IFN-c-induced surface
expression of MHC-II and CD64. The lspAgene encodes for a
prolipoprotein signal peptidase II that cleaves the signal sequence
from diacylatedprolipoproteins at a site that precedes the
lipidatedcysteine residue. This cleavage exposes the primary
amine group on the N-terminal cysteine that leads to final
acylation and formation of mature triacylated lipoproteins.
Disruption of lipoprotein signal peptidase results in loss of all
Figure 1. Exosomes isolated from M.tb infected cells inhibit IFN-c induced surface expression of MHC class II and CD64 on BMMØ.
Exosomes were isolated from uninfected RAW264.7 cells (Un exo) or RAW264.7 cells infected with M.tb H37Rv (Rvexo). BMMØ were treated with
exosomes for 18 hours or left untreated (RC) followed by +/2 IFN-c stimulation for an additional 18 hours. Cells were stained with either PE
conjugated anti-MHC class II or anti-CD64 and analyzed by flow cytometry. Shown are the number of cells stained with MHC class II (A) or CD64 (B)
and representative FACS plots for each treatment; MHC-II (C) and CD64 (D). Isotype control antibody was used to define background staining. Results
are representative of three individual experiments plus standard deviations; asterisk (*) indicates a p value #0.05 between +/2 IFN-c treatments.
doi:10.1371/journal.pone.0018564.g001
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-
infected cells alone induced a limited increase in MHC class II
expression similar to what was observed for exosomes from wild-
type H37Rv-infected cells. Moreover, both exosome preparations
inhibited the IFN-c induced MHC class II expression (Fig. 2A and
2C). In contrast, the exosomes from H37Rv lspA
- infected cells
neither induced CD64 expression nor were they able to inhibit the
IFN-c-induced CD64 expression, suggesting differential inhibition
of IFN-c responsive genes in presence/absence of mycobacterial
lipoproteins (Fig. 2B and 2D). The reason for this difference is not
clear but may reflect a quantitative difference in TLR2 ligation in
the presence or absence of lipoproteins. This may lead to
differences in the level of NF-kB activation or other signaling
changes resulting in the distinct responses observed with the
exosomes.
Nevertheless, exosome-mediated suppression of IFN-c-induced
MHC class II and CD64 expression was completely dependent on
TLR2 (Fig. 3A and 3B) and MyD88 (data not shown) as
macrophages deficient in either protein were refractory to the
exosome-mediated inhibition of IFN-c activation. Interestingly,
the limited upregulation of MHC class II expression induced by
exosomes was not dependent on TLR2 (Fig. 3A).
Since M.tb-infected macrophages secrete IL-6 which may
contribute to their inhibition of IFN-c activation [18], we tested
the cell culture supernatants from exosome-treated BMMØ for IL-
6 levels. We found that although treatment of BMMØ with
exosomes from infected cells resulted in higher levels of IL-6 in
comparison to treatment with exosomes from uninfected cells,
neither supernatants were capable of suppressing IFN-c-induced
MHC-II and CD64 expression (data not shown).
Exosomes from M.tb-infected cells do not block IFN-c
induced STAT1 phosphorylation but do block CIITA
expression
To determine if exosomes block the initial steps in the JAK-
STAT pathway we looked at STAT1 phosphorylation following
IFN-c stimulation. As observed previously with M.tb and its TLR2
Figure 2. Exosome-mediated inhibition of MHC-II and CD64 expression is partially dependent on exosomes containing
mycobacterial lipoproteins. Exosomes were isolated from RAW264.7macrophages infected with wild-type or LspA-deficient M.tb. BMMØ were
treated with the exosomes or left untreated (RC) for 18 hours and then incubated for an additional 18 hours +/2 IFN- c. Cells were stained with PE-
conjugated anti-MHC class II or anti-CD64 antibody and analyzed by flow cytometry. Isotype control antibodies were used to define background
staining. Shown is the mean fluorescence intensity for each sample with isotype control values subtracted from each value for MHC-II (A) and CD64
(B). Also shown are the representative FACS plots for MHC-II (C) and CD64 (D) expression. Results are representative of two independent experiments
plus standard deviation and p value ,0.05 between +/2 IFN-c treatments are indicated by asterisk (*).
doi:10.1371/journal.pone.0018564.g002
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-
H37Rv-infected cells did not inhibit phosphorylation of STAT1 at
Tyr 701 (Fig. 4A). Previous studies have shown that the M.tb 19-
kDa lipoprotein inhibits class II major histocompatibity complex
transactivator (CIITA) expression normally induced by IFN-c
treatment [20]. CIITA is a master regulator of MHC class II
expression and appears to promote transcription factor binding to
the MHC class II promoter facilitating transcription [21]. To
determine whether pre-treatment of macrophages with exosomes
also blocks IFN-c-induced CIITA expression, real time PCR was
performed to measure CIITA mRNA levels. The results showed
that exosomes from wild-type or lspA
- H37Rv-infected cells
inhibited IFN-c induced CIITA mRNA expression by 5 fold
and 3 fold respectively in comparison to treatment with IFN-c
alone (Fig. 4B). The CIITA mRNA levels on macrophages were
defined relative to the housekeeping gene GAPDH. Exosomes
from uninfected cells did not inhibit the IFN-c induced CIITA
mRNA expression (Fig. 4B).
Exosomes from M.tb-infected cells inhibit a subset of
IFN-c regulated genes
A microarray study was undertaken to define the gene
expression profile in response to exosome treatment on a global
scale. Primary C57BL/6 derived BMMØ were treated with
exosomes or infected with M.tb followed by incubation with or
without IFN-c. There were 8 treatment groups which included
BMMØ: +/2 IFN- c, Uninfected exosomes +/2 IFN-c, H37Rv
exosomes +/2 IFN- c and H37Rv infection +/2 IFN- c.
Macrophages were harvested for RNA which was converted to
double stranded cDNA, labeled with Cy3 and 4 mg of labeled
cDNA hybridized to Musmusculus 4672 whole genome array.
Results were drawn from three independent experiments and
expression values for treatment groups were normalized to
untreated macrophages. Genes were filtered on the basis of fold
change $2 and p value #0.05. Treatment of macrophages with
IFN-c induced the expression of 295 genes and suppression of 355
genes (Fig. 5A and B). Included in the upregulated genes are those
involved in antigen presentation such as MHC-II and CD64 as
well as CD40, CIITA, CD86 and H2-Mb2. Other genes
upregulated by IFN-c include those involved in cell attachment
and recruitment (e.g. ICAM-1, CCR2 and CCR5) and GTP
binding proteins (e.g. guanylate binding proteins 2, 4 and 5, IRG-
47, LRG-47 and Interferon-c induced GTPase). Infection of
macrophages with M.tb resulted in the induction of 393 genes and
suppression of 300 genes whereas treatment with exosomes from
H37Rv-infected cells induced and suppressed 89 and 78 genes
respectively. A number of genes suppressed by exosomes are
involved in immune responses such as the nitric oxide synthase,
PGE2 synthase and HSP-70. Exosomes from uninfected cells
induced the expression of 5 genes that were all listed as
hypothetical and no suppressed genes were defined. M.tb infection
induced expression of many the same genes previous defined [22]
including Formyl peptide receptor, SOCS-3, TRAF-1 and Fas as
well as suppressed expression of Ccr2, Cyclin D1, Lymphocyte
specific protein, CD39 and CD83. There was a limited overlap in
up-regulated and down-regulated genes between any two
treatments with most of overlap observed between IFN-c
treatment and H37Rv infection. A complete list of the microarray
data associated with IFN-c, M.tb-infection and exosome-treatment
of BMMØ has been included as supplementary data (TableS1)
and submitted to Gene Expression Ominbus (GEO).
In this study, we were particularly interested in evaluating how
exosomes affect the macrophage response to IFN-c and how this
compares to M.tb-infected macrophages. We observed that of the
295 genes induced by IFN-c, 90 were not inhibited by any
treatment or infection (Fig. 5C). However, there were a significant
number of IFN-c inducible genes (94 in total) that were suppressed
by either pretreatment with H37Rv exosomes orH37Rv infection.
Interestingly, an additional 65 genes induced by IFN-c, were
specifically suppressed by H37Rv exosomes and similarly 46 IFN-
c inducible genes were uniquely suppressed in H37Rv infected
cells. Importantly, pretreatment of macrophages with exosomes
released from uninfected cells did not significantly affect any of the
genes induced by IFN-c. We also analyzed the genes suppressed
by IFN-c to determine if pre-treatment with H37Rv exosomes or
prior infection with M.tb‘‘rescued’’ gene expression. We found that
among the 355 genes suppressed by IFN-c, a significant number of
genes (165 in total) were not rescued by exosome treatment or
infection (Fig. 5D). However, there were a number of genes (73 in
total) rescued by either pretreatment with H37Rv exosomes or by
M.tb infection. An additional 68 genes were rescued only in
BMMØ treated with H37Rv exosomes and another 49 genes were
rescued only in M.tb-infected cells. Again, pretreatment with
exosomes from uninfected cells had no effect on IFN-c regulated
gene expression. A complete list of the microarray data associated
with IFN-c-regulated genes affected by exosomes treatmentand
M.tb infection can be found in supplementary data (Table S2) and
has been submitted to GEO.
Figure 3. Theinhibition of MHC class II and CD64 by
Rvexosomesis dependent on macrophage expression of
TLR2. Untreated or exosome-treated BMMØ isolated from TLR2-
deficient mice were stimulated +/2 IFN-c. Macrophages were
harvested, stained with PE-conjugated anti-MHC class II or anti-CD64
antibody and analyzed by flow cytometry. Shown are the mean
fluorescence intensity values for MHC-II (A) and CD64 (B) expression.
Results are representative of two independent experiments plus
standard deviation and p value ,0.05 between +/2 IFN-c treatments
are indicated by asterisk (*).
doi:10.1371/journal.pone.0018564.g003
Exosomes Block Macrophage Activation by IFN-c
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are affected by H37Rv exosome treatment and includes the genes
most altered by exosome treatment based on fold differences in
gene expression. Also included is a subset of genes likely associated
with M.tb immunity taken from the complete list of IFN-c-
regulated genes modulated by H37Rv exosome treatment. These
genes fall into various categories including genes important in
antigen presentation (i.e CIITA, class II MHC, CD86), apoptosis
(i.eFas, caspase 3) and complement components. Of note, the
majority of the genes listed were also suppressed by M.tbinfection.
We were particularly interested in the exosome-mediated
suppression of Irgm mRNA expression which was confirmed by
qRT-PCR (data not shown). Irgm is a GTP-binding protein which
appears to play a critical role in the anti-mycobacterial response
induced by IFN-c [5].
To categorize the differentially regulated genes functionally, we
initiated a KEGG pathway analysis using web based Pathway-
Express program of the Onto-tools Suite. This led to identification
of 6 major pathways that were down-regulated in cells treated with
H37Rv exosomes and IFN-c compared to IFN-c treatment alone
(Table 2). These pathways were selected on the basis of corrected
gamma p value #0.05 and a minimum input of 4 genes. Most
significantly affected pathways included those involved in Cell
adhesion and Cytokine-cytokine receptor interaction. Other
affected pathways include the antigen processing and presentation
pathway, Toll-like receptor signaling pathway, apoptosis and
complement and coagulation pathway.
Discussion
Our results suggest that exosomes released from M.tb H37Rv-
infected cells when added to BMMØ can partially block the cells
response to IFN-c stimulation, including inhibiting MHC class II
expression. The mechanism by which exosome inhibit the IFN-c
response appears similar to what has been shown with the 19-kDa
lipoprotein and M.tb infection, as the proximal step in STAT1
activation appear not to be affected but expression of CIITA is
down-regulated [19,20,22,23,24,25]. This inhibitory effect of
exosomes is partially dependent on the presence of M.tb
lipoproteins but completely dependent on the macrophage
expression of TLR2 and MyD88. Finally, in line with previous
studies with M.tb-infected macrophages or purified lipoprotein, the
exosomes only block a subset of IFN-c inducible genes [22].
Although a significant body of research has addressed the
mycobacterial components that can inhibit IFN-c stimulation
as well as define the mechanism behind this inhibition
[9,10,11,20,22,25], it remains unclear whether these components
would be acting only in the context of whole mycobacteria and
therefore only within infected cells or if they may function outside
this sphere. The latter requires that the components are shed while
the mycobacteria remain extracellular or that they are released
from infected cells. Although, published data indicates that M.tb
may remain extracellular during a latent infection [26], studies
suggest that only limited number of bacilli remain extracellular
during an active infection [27]. Nevertheless, it is clear that
Figure 4. Exosomes from M.tb-infected cells do not block IFN-c induced STAT1 phosphorylation but do inhibit IFN-c induced
expression of CIITA. BMMØ were treated +/2 exosomes isolated from RAW264.7 macrophagesas described for figure 1 followed by a 30 minute
incubation with IFN-c. Cells were lysed and analyzed by Western blot for p-STAT1 (Tyr701) (A). The p44/42 MAP Kinase antibody was used as a
loading control as described previously (17). BMMØ were treated with exosomes and stimulated +/2 IFN-c for 18 hours. Cells were harvested for qRT-
PCR using specific primers for target gene (CIITA) and reference gene (GAPDH). Shown is the relative mRNA expression compared to untreated cells
for CIITA normalized to GAPDH (B). Results are representative of two separate experiments plus standard deviation and p value ,0.05 shown by
asterisk (*).
doi:10.1371/journal.pone.0018564.g004
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can be found at high concentrations within TB granulomas in
human patients and likely functions in promoting caseatinggra-
nulomas and secondary tuberculosis [28]. How cord factor
accumulates in the extracellular environment is unclear, although
experiments by Beatty et al. indicate that it is released from infected
macrophages on small membrane-bound vesicles [29]. However,
most studies to address mechanisms by which mycobacterial
components are released from infected cells have focused on
apoptosis. Apoptotic vesicles isolated from BCG-infected macro-
phages can activate both CD4+ and CD8+ T cells in vivo [30].
Earlier studies have shown that apoptotic bodies from infected
macrophages carry a number of mycobacterial antigens [31]. Our
recent work indicates that mycobacterial proteins and glycolipids
are present on exosomes released from macrophages infected with
M.tbor other mycobacteria [32].
Exosomes are small 30–100 nm membrane vesicles derived
from the fusion of MVBs with the plasma membrane and release
of the intraluminal vesicles as exosomes. The exosomes are
released from both hematopoietic and non-hematopoietic cells and
function in transporting proteins, lipids and RNA to other cells
and in doing so may modulate their cellular functions [33]. The
role for exosomes in biological processes has garnered considerable
attention recently, mostly in the context of tumor antigen
presentation and activation of CD4+ and CD8+ T cells
[34,35,36]. However, exosomes have also been shown to inhibit
immune responses. Studies by Pecheet al. demonstrated that by
injecting donor-haplotypeexosomes from bone marrow DCs
before transplantation one could significantly prolong heart
allograft survival in congenic and fully MHC mismatched Lewis
rats [37]. Exosomes may also be involved in promoting tolerance
to oral antigens [38]. Therefore, whether exosomes promote or
suppress an immune response depend on various factors including
source and composition of the exosomes as well as the system
under investigation. In previous studies we have shown that
exosomes from M.tb-infected macrophages can stimulate naı ¨ve
Figure 5. Exosomes isolated from M.tb-infected cells inhibit a subset of IFN-c inducible genes which partially overlaps with those
inhibited by an M.tb infection. BMMØ were treated with exosomes isolated from RAW264.7 cells (uninfected/infected)or were infected with M.tb
followed by incubation +/2 IFN-c. RNA was isolated, converted to double-stranded cDNA, labeled with Cy3 and hybridized to Musmusculus 4672
whole genome array. Genes up-regulated or down-regulated by each treatment were identified on the basis of $2 fold change in gene expression
and a p value #0.05 as defined through three independent microarray experiments. Results are represented as Venn diagrams showing the total
number of genes identified as well as the number of genes which overlap between treatment groups (A and B). Genes induced by IFN-c were further
analyzed for suppression by exosome pre-treatment or H37Rv infection. Similar analysis was performed on genes suppressed by IFN-c whose
expression was ‘‘rescued’’ by exosome pre-treatment or H37Rv infection. Results are depicted as pie charts showing the number of IFN-c-induced
genes not inhibited by any treatment, those inhibited by treatment or infection and those common to both groups (C). Similarly, results are shown
for genes rescued by exosomes or H37Rv infection (D).
doi:10.1371/journal.pone.0018564.g005
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other pro-inflammatory mediators [15]. In the present study we
have shown they can also enhance MHC class II cell-surface
expression. Nevertheless, pre-treatment of BMMØ with exosomes
from M.tb-infected but not from uninfected cells can render these
macrophages partially refractory to IFN-c stimulation.
In previous studies by Paiet al. they observed a significant
number of macrophage/host genes whose expression was
modulated by exposure to the M.tb 19-kDa lipoprotein (459 genes
in total). Interestingly, despite the known presence of the 19-kDa
lipoprotein on exosomes, we did not observe such modulation of
macrophage gene expression upon exposure to exosomes from
M.tb-infected macrophages (167 genes in total). This might be due
to differences in the concentration of the 19-kDa lipoprotein as the
exosomes would likely contain significant less of the lipoprotein
then used in the studies by Paiet al. The variation may also stem
from differences in the experimental systems, as the previous
microarray studies used macrophages exposed to the 19-kDa
lipoprotein during the entire experiment while in our studies, the
BMMØ were exposed to exosomes only during the first 18 hours
and removed during the 18 hour incubation with IFN-c.I ti s
important to note that our study was not specifically designed to
Table 1. List of genes suppressed or rescued by exosomes isolated from M.tb infected cells following stimulation with IFN-c.
IFN- c inducible genes suppressed by Rvexosomes Genes rescued by Rvexosomes from IFN- c mediated suppression
Ten most regulated genes
Gene Fold change Gene Fold change
Cnn3, calponin 3, acidic 221.67* Edg1,endothelial differentiation 15.06*
Bcl2l14, Bcl-2 like14 217.09* sphingolipid G-protein coupled receptor1
(apoptosis facilitator) Ccl9 11.75*
Mpa2l,macrophage activation 2 like 214.49* Clec4d, C-type lectin domain4 11.03*
Cxcl10,(chemokine C-X-C motif) 213.15* Lhfpl2,lipoma HMGIC 10.7*
Ligand 10 fusion partner like 2
Cd274 29.54* Igf1, insulin like growth factor1 10.28*
Slamf8,SLAM family member8 27.39* Fabp4,fatty acid binding protein4 10.14*
Gbp5,guanylate nucleotide binding protein5 27.04* Igfbp4,insulin like growth factor binding protein4 9.75*
Lrrc8c, Leucine rich repeat containing 8 family member C 26.96* cbr2, carbonyl reductase2 7.78*
TimD4,T-cell immunoglobulin 26.82* Emp1,epithelial membrane protein1 7.28*
Cd40 26.70* Xylt2, xylosyltransferase2 6.68*
Ten most interesting genes
C2ta, classIItransactivator 24.41* C5ar1,complement component 5a receptor1 4.3*
Cd86 23.55* Cd14 4.19*
Fas, Tnfrsf6 (TNF receptor superfamily member) 23.38 Mrc1, mannose receptor C,type1 4.04
H2-DMb2, histcompatibility2,classII, locusMb2 23.08* Ccr3 3.98*
irf1,interferon regulatory factor1 22.87* Pik3cg 3.34*
Ccl5, RANTES 22.97 Cd84 3.24*
irgm, LRG-47,immunity related GTPase 22.35* Ccl3 2.90*
Caspase3 22.43 Ccl4 3.1*
C3, complement component 3 22.62 Ets-1 2.25*
C1r, Complement component1,r 22.25 Cxcr4 4.44*
*Genes common to both treatment with Rv exosomes/H37Rv infection.
doi:10.1371/journal.pone.0018564.t001
Table 2. IFN-c stimulated pathways significantly inhibited by Rvexosomes.
Pathway No of genes Gamma p value Representative genes
Cell adhesion molecules 10 2.26E-06 Itgb7, CD40, CD274, CD86, Icam1
Cytokine-cytokine receptor interaction 10 9.11E-05 Il15ra, il18, ccl12, ccl5, cxcl10
Antigen processing and presentation 6 0.001 H2-T22, ciita, H2- DMb2, H2-Oa,Tap1, H2-DMa
Toll-like-receptor signaling pathway 8 0.002 Irf-7, tnf, CD40, Tlr9
Complement and coagulation cascades 4 0.003 Clr, c3, c1s, cfb
Apoptosis 7 0.005 Fas, TNF, Casp3, Bid
doi:10.1371/journal.pone.0018564.t002
Exosomes Block Macrophage Activation by IFN-c
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Nevertheless, it is clear that exosomes can modulate macrophage
gene expression and that this is specific to exosomes from infected
cells as exosomes from uninfected macrophages were relatively
inert. As expected, infection of macrophages with H37Rv induced
significant changes in gene expression and was comparable to
what was observed in earlier studies [22].
Our study indicates that exosomes from M.tb-infected macro-
phages can block a significant number of IFN-c-induced or
suppressed genes. A majority of these IFN-c regulated genes were
also blocked in M.tb-infected macrophages and include genes
involved in antigen presentation and macrophage activation (see
Table 1). Indeed all 10 genes which showed the highest change in
gene expression between IFN-c treatment +/2 exosomes were
also affected by infection with M.tb. Nevertheless, there were also
IFN-c regulated genes specifically affected by treatment with
exosomes or infection with H37Rv. This likely stems from the
different receptors engaged by H37Rv and exosomes and the
continued presence of the mycobacteria and mycobacterial
components during the course of the experiment. Our previous
studies indicate that exosomes function through TLR2 and
MyD88 to induce macrophage production of TNF-a and other
cytokines [15] and this engagement also appears important in
modulating the macrophage response to IFN-c; however, we
cannot rule out the importance of other receptors potential
engaged by exosomes.
In summary, the present as well as our previous studies suggest
that the exosome’s effect on the immune response is dynamic and
multifactorial. Exosomes released from M.tb-infected macrophages
can both promote and inhibit aspects of mycobacterial immunity.
To what extent exosomes perform such functions during the
course of an in vivo infection awaits further study and will require




The University of Notre Dame is credited through the Animal
Welfare Assurance (#A3093-01). All animal studies were con-
ducted according to the Institutional Animal Care and Use
Committee (IACUC) guidelines. The protocol for the isolation of
macrophages from mice was approved by the University’s IACUC
(March 26, 2009, protocol # 11-034).
Macrophage culture and bacterial strains
Bone marrow derived macrophages (BMMØ) were isolated
from 6–8 weeks old female C57BL6 mice and cultured in vitro as
previously described [39]. The mouse macrophage cell line RAW
264.7 was maintained in RPMI supplemented with 10% fetal
bovine serum, 10 mM sodium pyruvate and 25 mM HEPES.
wild-type and the LspA-deficient H37Rv (kindly provided by Joel
Ernst, NYU, New York) were each grown in Middlebrook 7H9
broth supplemented with OADC until mid logarithmic growth
phase and frozen down as stocks in growth media plus 15%
glycerol. Prior to use, H37Rv stocks were thawed and the
mycobacteria were de-clumped bya brief sonication and passing
through syringe fitted with 27 gauge needle at least ten times.
Isolation of exosomes from cell culture supernatants
Confluent monolayers of RAW 264.7 mouse macrophage cell
line were infected with mycobacteria or left uninfected as controls.
Before infection, the bacterial cultures were incubated for 2 hours
with normal horse serum for complement opsonization. Infections
with M.tb were titrated to obtain approximately 80% infectivity.
The RAW 264.7 cells were infected with bacteria for 4 hours
followed by washes with 1X DPBS. The cells were cultured in
RPMI containing exosome free FBS (10% final concentration) and
exosomes were isolated from the culture supernatants of infected
and uninfected RAW 264.7cells after 72 hours and purified on
linear sucrose gradient as previously described [40].
Treatment of macrophages with exosomes and IFN-c
BMMØ were seeded in six well tissue culture plates @ 7.5610
5
cells/well and allowed to adhere for 24 hours. The cells were
treated with exosomes isolated from uninfected and infected RAW
cells at 10 mg/well for 18 hours. The media was removed and
replenished with fresh media +/2 recombinant mouse IFN-c
(eBioscience Inc. San Diego, CA) at 200 U for an additional
18 hours.
Flow cytometry
The cells were rinsed with DPBS and gently scraped and
counted on hemacytometer using trypan blue to assess viability.
The cells were washed in FACS buffer and blocked with 10%
mouse serum and stained with PE conjugated anti-mouse I-A/I-E
or FccR1 (CD 64) or isotype control (BD Pharmingen, San Jose,
CA). Cells were analyzed for protein surface expression using a
Beckman Coulter flow cytometer. Cellular fluorescence was also
quantified by the geometric mean (Gmean). For this fluorescence
analysis, the GMean fluorescence for isotype control was deducted
from the GMean fluorescence for the specific antibody.
Immunoblot
To study phosphorylation of STAT1, the bone marrow
macrophages were treated with exosomes for 18 hours as described
above. Cells were treated with 200 U recombinant mouse IFN-cor
leftuntreatedfor 15 minutes to an hour. Cells were then lysed on ice
in immunoprecipitation buffer with protease and phosphatase
inhibitors (20 mMTris.HCl, 50 mMNaCl, 1 mM EGTA, 1% NP-
40, 1% Sodium deoxycholate, 2.5 mM sodium pyrophosphate,
1 mM sodium vanadate, 1 mM EDTA, 1 mM Dithiothreitol,
1 mM PMSF 0.1% SDS and 10 mM sodium fluoride). The protein
lysates were quantified by Micro BCA protein assay and equal
concentrations of each group were loaded on 10% SDS-PAGE gels,
electrophoresed and transferred onto polyvinylidenedifluoride
membranes (Milipore, Bedford, MA). The membranes were probed
with (1/1000 dilution) p-Stat1 (Tyr 701) (Santa Cruz Biotechnology
Inc. Santa Cruz, CA) and with goat anti-mouse HRP (1/15000
dilution) and developed using Super Signal West Pico chemilumi-
niscent substrate (Pierce, Thermo Fisher Scientific, Rockford, IL).
The p44/42MAP Kinase antibody (Cell Signaling Technology Inc.
Beverly, MA) was used as a loading control as previously described
[41].
Quantitative Real time PCR
RNA was isolated using RNeasy columns (Qiagen Inc.
Valencia, CA) following manufacturer’s instructions and quanti-
fied by Nanodropspectrophotometric method. 1 mg of RNA was
converted to cDNA using Verso cDNA kit (Thermoscientific). One
tenth of the resulting cDNA template was used for Real-time PCR
using Absolute QPCR SYBR Green Mix (Thermo Scientific) and
7500 Fast Real Time PCR system (Applied Biosystems). The
following primers were obtained commercially from Invitrogen:
CIITA sense, 59-ACG CTT TCT GGC TGG ATT AGT-39;
CIITA antisense,59-TCA ACG CCA GTC TGA CGA AGG-39
and GAPDH sense, 59-AAC GAC CCC TTC ATT GAC-39,
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[25]. PCR amplification efficiencies were determined for each
gene prior to the relative quantification and were similar for the
target gene (CIITA) and the endogenous control (GAPDH).
Dissociation curve analysis was also run for each reaction to detect
nonspecific amplification in cDNA samples. The relative mRNA
expression of the target gene normalized to the endogenous
reference gene was quantitated using the comparative Ct method
and the formula 2
-DDC
T.
Nimblegen Microarray gene expression studies
Macrophages were treated with exosomes at10 mg/well,
infected with M.tb H37Rv or left untreated for 18 hours followed
by +/2 IFN-c at 200 U/ml for an additional 18 hours. Cells were
harvested and RNA was isolated using RNeasy columns (Qiagen).
Double stranded cDNA was synthesized using the Invitrogen
Superscript Double-Stranded cDNA synthesis kit and was
subsequently labeled using Nimblegen one color DNA labeling
kit (Roche Nimblegen Inc. WI). 4 mg of Cy3-labeled cDNA from
each group was hybridized onto Musmusculus 4672 Nimblegen
microarray using Nimblegen Hybridization system 4 according to
manufacturer’s instructions (Roche). Arrays were scanned and
chip images were collected on a Nimblegen MS200 station
running Nimblegen 1.0 software. The microarray gene expression
analysis was performed using data generated from three
independent experiments. All genes that fell within one standard
deviation of the average chip background in at least two thirds of
treatment conditions were removed from consideration before any
other analysis was performed. P values for differences in individual
gene expression values were calculated using the student t-test.
Separate gene lists were constructed for up- and down-regulated
genes for each of the three treatment conditions by screening with
the criteria of mean expression value of $2 fold over untreated
cells and a p value #0.05. From the list of IFN-c induced genes
(determined by the above criteria) a gene was considered
suppressed by exosome treatment or H37Rv infection if it showed
at least 2 fold down regulation relative to IFN-c treatment with p
value ,0.05. Similarly, an IFN-c suppressed gene was considered
rescued if it showed at least 2 fold increase in expression level
relative to IFN- c treatment with a p value ,0.05.
Pathway analysis was performed with the Pathway-Express
program [42] of the Onto-tools Suite. For this analysis, genes were
selected based solely on the criterion of a 2 fold cut-off. The
analysis was performed assuming a hypergeometric distribution
and using the Bonferroni multiple testing correction. Affected
KEGG pathways were ranked in order of classical p-values as well
as gamma corrected p-values, which refers to pathway impact
analysis or a measure of the probability of a pathway being
significantly regulated.
Statistical analyses. Data was analyzed by a one-tailed or
paired Student’s t test. Statistical significance was assumed at p
#0.05. Each experiment was conducted 2 or 3 times and error
bars represent standard deviation values.
Supporting Information
Table S1 List of genes suppressed or rescued by exosomes
isolated from M.tb infected cells following stimulation with IFN-c.
(XLSX)
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